ROS1-Rearranged Lung Adenocarcinoma: From Molecular Genetics to Target Therapy.
- Published in:
- Onco, 2023, v. 3, n. 3, p. 189, doi. 10.3390/onco3030014
- By:
- Publication type:
- Article
Works matching IS 26737523 AND DT 2023 AND VI 3 AND IP 3
Results: 5
1
2
Machine Learning-Based Model Helps to Decide which Patients May Benefit from Pancreatoduodenectomy.
- Published in:
- Onco, 2023, v. 3, n. 3, p. 175, doi. 10.3390/onco3030013
- By:
- Publication type:
- Article
3
Peripheral Blood CD8+ T-Lymphocyte Subsets Are Associated with Prognosis in Prostate Cancer Patients.
- Published in:
- Onco, 2023, v. 3, n. 3, p. 165, doi. 10.3390/onco3030012
- By:
- Publication type:
- Article
4
NUP98 Rearrangements in AML: Molecular Mechanisms and Clinical Implications.
- Published in:
- Onco, 2023, v. 3, n. 3, p. 147, doi. 10.3390/onco3030011
- By:
- Publication type:
- Article
5
Precision Medicine Revolutionizing Esophageal Cancer Treatment: Surmounting Hurdles and Enhancing Therapeutic Efficacy through Targeted Drug Therapies.
- Published in:
- Onco, 2023, v. 3, n. 3, p. 127, doi. 10.3390/onco3030010
- By:
- Publication type:
- Article